Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

(LLL, PWRM.OB, FSTR, ID, LB) Stock Report from

|Includes:FSTR, ID, LB-OLD, L-3 Communications Holdings Inc. (LLL)




L-3 Communications (NYSE: LLL) intends to release its 2010 third quarter results on Thursday, October 28, 2010 before the open of the market.

In conjunction with this announcement, LLL will host a conference call on the same day at 11:00 a.m. EDT that will be simultaneously broadcast over the Internet.

Michael T. Strianese, chairman, president and chief executive officer, and Ralph G. D’Ambrosio, senior vice president and chief financial officer, will host the call.


power3 PWRM, Power 3 Medical Products Inc., PWRM.OB

PWRM is a leader in bio-medical research and the commercialization of neurodegenerative disease and cancer biomarkers, pathways, and mechanisms of diseases through the development of diagnostic tests and drug targets.

** PWRM has signed a definitive agreement to acquire all of the stock of Rozetta-Cell Life Sciences, Inc.

PWRM plans to effectuate the acquisition of Rozetta-Cell by merging Rozetta-Cell with and into PWRM, with PWRM remaining as the surviving company in the merger. The acquisition of Rozetta-Cell is expected to be completed in October or November 2010.

Rozetta-Cell is a medical biotechnology company that focuses on the delivery and imaging of stem cells during therapy. The company has a robust intellectual property portfolio and has created numerous products for adult stem cell therapy that are ready for market globally. Rozetta-Cell also has several collaborations in process through which it is partnering with industry-leading adult stem cell research companies and adult stem cell vendors.

"We are very excited to be acquiring Rozetta-Cell Life Sciences," stated Ira L. Goldknopf, President and Chief Scientific Officer of PWRM. "Rozetta-Cell brings us a tremendous amount of complementary adult stem cell therapy technology, know-how and experience. With the addition of Rozetta-Cell, Power3 will significantly strengthen its IP portfolio in a major growth market by merging regenerative medicine with the technologies that we are using to identify disease-specific protein biomarkers and develop them into screening and diagnostic tests to address unmet medical needs."

More about PWRM at


L.B. Foster Company (Nasdaq:FSTR) of Pittsburgh, PA is providing new roadway decking and bridge railing for the Brooklyn and Manhattan approach ramps to the famed Brooklyn Bridge.

The $10 million  contract will include more than 170,000 square feet of steel grid deck and 13,000 linear feet of steel railing. These fabricated materials are being manufactured at FSTR's Bedford, PA facility and expect to complete shipments by the end of 2011


L-1 Identity Solutions, Inc. (NYSE: ID), a leading provider of identity solutions and services, recently reported that it received a $5.5 million order from an existing U.S. government customer for ABIS (Automated Biometric Identification System) license capacity.

The order increases the existing operating capacity of ABIS system software currently being utilized by the U.S. Department of Defense.


LaBarge, Inc. (Amex: LB), a provider of electronics manufacturing services (NYSE:EMS), has been awarded recently a $1 million contract from LORD Corporation to produce electronic assemblies for military and civilian helicopters. LaBarge anticipates follow-on orders.


Signup for FREE Daily Stock Alerts From


Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services from Power 3 Medical Products Inc. (OTC:PWRM).